The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis

American Journal of Hypertension

Volumn 13, Issue 4, 2000, Pages 433-437

  Mallamaci, F ^a,b   Zuccala A ^c   Zoccali, C ^a,b   Testa, A ^a   Gaggi, R ^c   Spoto, B ^a   Martorano, C ^a,b   Curatola, A ^a   Misefari, V ^a   Cuzzola, F ^a   Romeo, G ^a   Zucchelli, P ^c  

^a CNR   (Italy)

^b Div Nefrologia   (Italy)

^c Ospedale M Malpighi   (Italy)

Author keywords

ACE; ACE genotype; Hypertension; Nephroangiosclerosis; Nephrosclerosis; Renal diseases

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; ENZYME POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; ITALY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; RACE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; NEPHROSCLEROSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENAL CIRCULATION;

EID: 0034067134     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00195-8     Document Type: Article

References (18)

1. Butler R, Morris AD, Struthers AD: Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci (Colch) 1997;93:391-400.
2. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997;15:1579-1592.
3. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998;97:1766-1772.
4. Schmidt S, Ritz E: The role of angiotensin I-converting enzyme gene polymorphism in renal diseases. Curr Opin Nephrol Hypertens 1996;5:552-555.
5. Schmidt S, Ritz E: Genetics of the renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens 1997;6:146-151.
6. Koomans HA, Joles JA, Rabelink TJ: Hypertension and the kidney: culprit and victim. Nephrol Dial Transplant 1996;11:1961-1966.
7. Fernandez-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L: Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 1998;53:1743-1747.
8. Staessen JA, Ginocchio G, Wang JG, Saavedra AP, Soubrier F, Vlietinck R, Fagard R: Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovas Risk 1997;4:401-422.
9. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20: 1433.
10. Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-121.
11. Hunley TE, Julian BA, Phillips JA III, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996;49:571-577.
12. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, Clarkson AR, Ponticelli C, Campise M, Mayer G, et al: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995;26: 727-731.
13. Tracy RE, Berenson GS, Cueto-Garcia L, Wattigney WA, Barrett TJ: Nephrosclerosis and aortic atherosclerosis from age 6 to 70 years in the United States, and Mexico. Virchows Arch A Pathol Anat Histopathol 1992;420:479-488.
14. Zucchelli P, Zuccala A, Gaggi: Primary hypertension as a cause of end-stage renal failure, in Clinical Hypertension in Nephrology. Editor C. Zoccali. Contrib Nephrol 1994;109:70-5.
15. Schlessinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994;23:655-660.
16. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T, Matsuo M, Shimada K: Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vasc Biol 1997;17:252-256.
17. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Bobola N, Ravazzolo R, Sacchi G, Deferrari G: The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996;7:2550-2558.
18. Boulahrouz R, Autuly V, Charasse C, Le Cacheux P, Ang KS, Ramee MP, Simon P: [A familial history of hypertension is associated with the development of hypertension and nephroangiosclerosis in patients with glomerulonephritis caused by mesangial IgA deposits]. Arch Mal Coeur Vaiss 1996;89:1065-1068.